Search
Lyell Immunopharma Inc
LYELAdd to Watchlist
12.750USD
-0.090-0.70%
Close 07-23 16:00（ET）Quotes delayed by 15 min
297.43MMarket Cap
LossP/E TTM
LYEL Financials
See Lyell Immunopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Lyell Immunopharma Inc Earnings Date
Latest Release
May 6, 2026
EPS / Forecast
-1.10/-2.37
Revenue / Forecast
2.00K/4.40K
Period
FY2025 Earnings
Revenue(YoY)
36.00K
-40.98%
EPS(YoY)
-16.06
38.80%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its total revenue reached 36.00K, with a year-on-year change of 61.00K.
What are the current assets of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its current assets were 260.94M, with a year-on-year change of -31.26.
What are the total assets of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its total assets of Lyell Immunopharma Inc were 340.05M, with a year-on-year change of -30.72.
What are the total liabilities of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its total liabilities of Lyell Immunopharma Inc were 91.85M, with a year-on-year change of -14.98.
What is the total equity of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its total equity of Lyell Immunopharma Inc was 248.20M, with a year-on-year change of -35.17.
What is the net operating income of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its net operating income of Lyell Immunopharma Inc was -201.63M, with a year-on-year change of 8.95.
What is the net investment of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its net investment of Lyell Immunopharma Inc was 54.10M, with a year-on-year change of -55.81.
What is the net financing of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its net financing of Lyell Immunopharma Inc was 50.41M, with a year-on-year change of 3701.36.
What is the Earnings Per Share (EPS) of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -16.06, with a year-on-year change of 38.80.
What is the net income of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its net income was -274.45M, with a year-on-year change of 19.98.
What is the net margin of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its net profit margin was -762355.56, with a year-on-year change of -35.58.
What is the Return on Equity (ROE) of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -86.98, with a year-on-year change of -31.59.
What is the Return on Assets (ROA) of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -66.06, with a year-on-year change of -19.50.
What is the operating profit of Lyell Immunopharma Inc?
According to Lyell Immunopharma Inc's FY2025 earnings report, its operating profit was -201.63M, with a year-on-year change of 8.95.